Perspective Therapeutics (FRA:AAJ) YoY EBITDA Growth : 44.74% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Perspective Therapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 44.74%.

Perspective Therapeutics's EBITDA per Share for the three months ended in Mar. 2024 was €-0.02.

Perspective Therapeutics YoY EBITDA Growth Historical Data

The historical data trend for Perspective Therapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics YoY EBITDA Growth Chart

Perspective Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

33.98

35.29

40.91

-84.62

-179.17

Perspective Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-375.00	-142.86	-13.79	-27.27	44.74

Perspective Therapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Perspective Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Jun. 2022 ))	/	\| EBITDA per Share (A: Jun. 2022 ) \|
=	(-0.134	-	-0.048)	/	\| -0.048 \|
=	-179.17 %

Perspective Therapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.021	-	-0.038)	/	\| -0.038 \|
=	44.74 %

Perspective Therapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ:Germany

Address

350 Hills Street, Suite 106, Richland, WA, USA, 99354

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines